Gemfibrozil, a Lipid-lowering Drug, Increases Myelin Genes in Human Oligodendrocytes via Peroxisome Proliferator-activated Receptor-β

An increase in CNS remyelination and a decrease in CNS inflammation are important steps to halt the progression of multiple sclerosis. Earlier studies have shown that gemfibrozil, a lipid-lowering drug, has anti-inflammatory properties. The current study identified another novel property of gemfibro...

Full description

Saved in:
Bibliographic Details
Main Authors: Jana, Malabendu, Mondal, Susanta, Gonzalez, Frank J., Pahan, Kalipada
Format: Artigo
Language:Inglês
Published: American Society for Biochemistry and Molecular Biology 2012
Subjects:
Signal Transduction
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3464522/
https://ncbi.nlm.nih.gov/pubmed/22879602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M112.398552
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items